![]() |
|||||||||||
Home | Founder | What's New | In The News | Consulting | |||||||
![]() |
|||||||||||
H1N1 Consulting Paradigm Shift Intervention Monitoring |
|
Audio:Jan18
Feb16
Mar15
Apr19
![]() ![]() Commentary Glycosylation
on Position 240 In H5N1 Ferret Transmission The recent H5N1 transmission paper in Nature has focused on the two changes acquired during passage in ferrets. The first change, N158D, abolished the glycosylation site in the H5 used by the Kawaoka study (which is also present in the H5 used in the Fouchier study, which has not yet been published in Science). Further passage of sequences which had N158D led to additional changes in H5 isolated from nasal washes, and most summaries have focused on the subsequent change, T318I, which was in a high titer collection (and T318I stabilized the virus). However, as cited above, 5 of the 6 ferrets had another change, A242S, which created a glycosylation site on the N at position 240. Moreover, ferrets infected with H5 containing N158D and T318I developed another change, A242T, (as seen in supplement table 5), which again created a gylycosylation site on the N at position 240. Thus, this change of A240S/T (which produces glycosylation at position 240) appears to be critical for ferret transmission via the constructs used in the Nature study. A242T is common in clade 2.2.1 F in Egypt, while N158D is common in clade 2.2.1 G in Egypt. The co-circulation of these two sub-clades with key changes leading to the creation and abolition of glycosylation sites increases pandemic concerns. Recombinomics
Presentations |
|||||||||
|
Webmaster:
webmaster@recombinomics.com
© 2012
Recombinomics. All
rights
reserved.